Loading...

Jyothy Laboratories

NSEI:JYOTHYLAB
Snowflake Description

Flawless balance sheet average dividend payer.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
JYOTHYLAB
NSEI
₹55B
Market Cap
  1. Home
  2. IN
  3. Household
Company description

Jyothy Laboratories Limited, together with its subsidiaries, manufactures and markets detergents, soaps, and mosquito repellents in India and internationally. The last earnings update was 12 days ago. More info.


Add to Portfolio Compare Print
  • Jyothy Laboratories has significant price volatility in the past 3 months.
JYOTHYLAB Share Price and Events
7 Day Returns
-4.9%
NSEI:JYOTHYLAB
2.7%
IN Household Products
-0.1%
IN Market
1 Year Returns
-32.5%
NSEI:JYOTHYLAB
6.8%
IN Household Products
-3.7%
IN Market
JYOTHYLAB Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Jyothy Laboratories (JYOTHYLAB) -4.9% -19.3% -14.4% -32.5% -3.6% 45.2%
IN Household Products 2.7% -0.6% -2.5% 6.8% 108.3% 203.5%
IN Market -0.1% -5% 4.7% -3.7% 34.5% 38.6%
1 Year Return vs Industry and Market
  • JYOTHYLAB underperformed the Household Products industry which returned 6.8% over the past year.
  • JYOTHYLAB underperformed the Market in India which returned -3.7% over the past year.
Price Volatility
JYOTHYLAB
Industry
5yr Volatility vs Market

Value

 Is Jyothy Laboratories undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Jyothy Laboratories to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Jyothy Laboratories.

NSEI:JYOTHYLAB Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 9 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 14.4%
Perpetual Growth Rate 10-Year IN Government Bond Rate 7.6%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NSEI:JYOTHYLAB
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year IN Govt Bond Rate 7.6%
Equity Risk Premium S&P Global 8.6%
Household Products Unlevered Beta Simply Wall St/ S&P Global 0.33
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.333 (1 + (1- 35%) (3.98%))
0.559
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 7.55% + (0.8 * 8.6%)
14.43%

Discounted Cash Flow Calculation for NSEI:JYOTHYLAB using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Jyothy Laboratories is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

NSEI:JYOTHYLAB DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (INR, Millions) Source Present Value
Discounted (@ 14.43%)
2019 1,938.25 Analyst x4 1,693.83
2020 2,030.25 Analyst x4 1,550.49
2021 2,245.00 Analyst x3 1,498.29
2022 2,607.00 Analyst x1 1,520.48
2023 2,849.79 Est @ 9.31% 1,452.49
2024 3,100.12 Est @ 8.78% 1,380.83
2025 3,360.97 Est @ 8.41% 1,308.23
2026 3,635.05 Est @ 8.15% 1,236.49
2027 3,924.88 Est @ 7.97% 1,166.72
2028 4,232.84 Est @ 7.85% 1,099.59
Present value of next 10 years cash flows ₹13,907.46
NSEI:JYOTHYLAB DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= ₹4,232.84 × (1 + 7.55%) ÷ (14.43% – 7.55%)
₹66,168.85
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= ₹66,168.85 ÷ (1 + 14.43%)10
₹17,189.16
NSEI:JYOTHYLAB Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= ₹13,907.46 + ₹17,189.16
₹31,096.62
Equity Value per Share
(INR)
= Total value / Shares Outstanding
= ₹31,096.62 / 367.21
₹84.68
NSEI:JYOTHYLAB Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in NSEI:JYOTHYLAB represents 0.99731x of BSE:532926
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.99731x
Value per Share
(Listing Adjusted, INR)
= Value per Share (INR) x Listing Adjustment Factor
= ₹ 84.68 x 0.99731
₹84.46
Value per share (INR) From above. ₹84.46
Current discount Discount to share price of ₹148.30
= -1 x (₹148.30 - ₹84.46) / ₹84.46
-75.6%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Jyothy Laboratories is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Jyothy Laboratories's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Jyothy Laboratories's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NSEI:JYOTHYLAB PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in INR ₹5.62
BSE:532926 Share Price ** BSE (2019-05-17) in INR ₹148.7
India Household Products Industry PE Ratio Median Figure of 5 Publicly-Listed Household Products Companies 26.46x
India Market PE Ratio Median Figure of 2,758 Publicly-Listed Companies 15.12x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Jyothy Laboratories.

NSEI:JYOTHYLAB PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= BSE:532926 Share Price ÷ EPS (both in INR)

= 148.7 ÷ 5.62

26.46x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Jyothy Laboratories is good value based on earnings compared to the IN Household Products industry average.
  • Jyothy Laboratories is overvalued based on earnings compared to the India market.
Price based on expected Growth
Does Jyothy Laboratories's expected growth come at a high price?
Raw Data
NSEI:JYOTHYLAB PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 26.46x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 9 Analysts
11.9%per year
Global Household Products Industry PEG Ratio Median Figure of 14 Publicly-Listed Household Products Companies 2.47x
India Market PEG Ratio Median Figure of 559 Publicly-Listed Companies 1.25x

*Line of best fit is calculated by linear regression .

NSEI:JYOTHYLAB PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 26.46x ÷ 11.9%

2.21x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Jyothy Laboratories is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Jyothy Laboratories's assets?
Raw Data
NSEI:JYOTHYLAB PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in INR ₹36.35
BSE:532926 Share Price * BSE (2019-05-17) in INR ₹148.7
India Household Products Industry PB Ratio Median Figure of 6 Publicly-Listed Household Products Companies 2.31x
India Market PB Ratio Median Figure of 3,638 Publicly-Listed Companies 1.02x
NSEI:JYOTHYLAB PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= BSE:532926 Share Price ÷ Book Value per Share (both in INR)

= 148.7 ÷ 36.35

4.09x

* Primary Listing of Jyothy Laboratories.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Jyothy Laboratories is overvalued based on assets compared to the IN Household Products industry average.
X
Value checks
We assess Jyothy Laboratories's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Household Products industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Household Products industry average (and greater than 0)? (1 check)
  5. Jyothy Laboratories has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Jyothy Laboratories expected to perform in the next 1 to 3 years based on estimates from 9 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
11.9%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Jyothy Laboratories expected to grow at an attractive rate?
  • Jyothy Laboratories's earnings growth is expected to exceed the low risk savings rate of 7.6%.
Growth vs Market Checks
  • Jyothy Laboratories's earnings growth is positive but not above the India market average.
  • Jyothy Laboratories's revenue growth is expected to exceed the India market average.
Annual Growth Rates Comparison
Raw Data
NSEI:JYOTHYLAB Future Growth Rates Data Sources
Data Point Source Value (per year)
NSEI:JYOTHYLAB Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 9 Analysts 11.9%
NSEI:JYOTHYLAB Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 9 Analysts 11.4%
Asia Household Products Industry Earnings Growth Rate Market Cap Weighted Average 15.1%
Global Household Products Industry Revenue Growth Rate Market Cap Weighted Average 4.2%
India Market Earnings Growth Rate Market Cap Weighted Average 16.8%
India Market Revenue Growth Rate Market Cap Weighted Average 10.4%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NSEI:JYOTHYLAB Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 9 Analyst Estimates (S&P Global) See Below
All numbers in INR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NSEI:JYOTHYLAB Future Estimates Data
Date (Data in INR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-03-31 26,187 2,950 3,014 2
2021-03-31 22,840 2,637 2,612 9
2020-03-31 20,261 2,318 2,232 8
NSEI:JYOTHYLAB Past Financials Data
Date (Data in INR Millions) Revenue Cash Flow Net Income *
2019-03-31 18,136 2,051
2018-03-31 17,494 2,435 1,861
2017-12-31 16,770 2,169
2017-09-30 16,327 2,038
2017-06-30 16,149 1,881
2017-03-31 16,847 1,633 2,081
2016-12-31 17,181 1,916
2016-09-30 17,064 1,903
2016-06-30 16,810 1,781

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Jyothy Laboratories's earnings are expected to grow by 11.9% yearly, however this is not considered high growth (20% yearly).
  • Jyothy Laboratories's revenue is expected to grow by 11.4% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NSEI:JYOTHYLAB Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 9 Analyst Estimates (S&P Global) See Below

All data from Jyothy Laboratories Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NSEI:JYOTHYLAB Future Estimates Data
Date (Data in INR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-03-31 8.20 8.20 8.20 1.00
2021-03-31 7.09 7.54 6.70 6.00
2020-03-31 6.08 6.20 6.00 5.00
NSEI:JYOTHYLAB Past Financials Data
Date (Data in INR Millions) EPS *
2019-03-31 5.62
2018-03-31 5.12
2017-12-31 5.87
2017-09-30 5.54
2017-06-30 5.13
2017-03-31 5.74
2016-12-31 5.29
2016-09-30 5.25
2016-06-30 4.92

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Jyothy Laboratories is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Jyothy Laboratories's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Asia market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Global market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Jyothy Laboratories has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Jyothy Laboratories performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Jyothy Laboratories's growth in the last year to its industry (Household Products).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Jyothy Laboratories's year on year earnings growth rate has been positive over the past 5 years.
  • Jyothy Laboratories's 1-year earnings growth is less than its 5-year average (10.2% vs 18.4%)
  • Jyothy Laboratories's earnings growth has exceeded the IN Household Products industry average in the past year (10.2% vs -10.4%).
Earnings and Revenue History
Jyothy Laboratories's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Jyothy Laboratories Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NSEI:JYOTHYLAB Past Revenue, Cash Flow and Net Income Data
Date (Data in INR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 18,135.80 2,050.90 3,203.20
2018-03-31 17,494.06 1,860.66 3,786.33
2017-12-31 16,769.52 2,169.36 3,457.28
2017-09-30 16,327.02 2,037.56 3,342.78
2017-06-30 16,149.32 1,881.06 3,291.18
2017-03-31 16,846.52 2,081.26 3,160.18
2016-12-31 17,181.05 1,916.00 3,971.07
2016-09-30 17,064.45 1,902.70 4,008.27
2016-06-30 16,809.75 1,781.00 4,019.97
2016-03-31 15,998.59 780.77 3,200.10
2015-12-31 15,959.37 1,494.04 5,314.28 5.25
2015-09-30 15,675.17 1,368.74 5,294.78 5.25
2015-06-30 15,344.57 1,232.34 5,230.68 5.25
2015-03-31 15,055.97 1,211.24 3,789.16
2014-12-31 14,652.40 1,155.15 4,677.38 4.88
2014-09-30 14,222.17 1,111.08 4,380.49 4.88
2014-06-30 13,710.78 992.09 4,123.19 4.88
2014-03-31 13,185.21 814.32 4,069.73 4.88
2013-03-31 11,042.39 196.48 3,307.03 2.38

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Jyothy Laboratories has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Jyothy Laboratories used its assets more efficiently than the IN Household Products industry average last year based on Return on Assets.
  • Jyothy Laboratories's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Jyothy Laboratories's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Household Products industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Jyothy Laboratories has a total score of 3/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Jyothy Laboratories's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Jyothy Laboratories's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Jyothy Laboratories is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Jyothy Laboratories's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Jyothy Laboratories's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 2.9x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Jyothy Laboratories Company Filings, last reported 1 month ago.

NSEI:JYOTHYLAB Past Debt and Equity Data
Date (Data in INR Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 13,050.70 2,173.90 2,071.70
2018-03-31 11,302.58 5,441.25 2,498.18
2017-12-31 10,204.10 6,661.40 1,614.60
2017-09-30 10,204.10 6,661.40 1,614.60
2017-06-30 10,823.60 4,982.65 1,318.99
2017-03-31 10,823.60 4,982.65 1,318.99
2016-12-31 9,558.50 514.00 1,573.90
2016-09-30 9,558.50 514.00 1,573.90
2016-06-30 8,478.34 4,508.24 1,494.89
2016-03-31 8,988.19 4,508.24 1,497.59
2015-12-31 8,831.80 5,499.60 1,712.90
2015-09-30 8,831.80 5,499.60 1,712.90
2015-06-30 7,810.97 5,693.74 2,703.51
2015-03-31 7,810.97 5,693.74 2,703.51
2014-12-31 8,059.19 5,314.10 988.21
2014-09-30 8,059.19 5,314.10 988.21
2014-06-30 7,359.56 5,335.96 1,301.69
2014-03-31 7,359.56 5,335.96 1,301.69
2013-03-31 6,434.31 6,295.35 473.85
  • Jyothy Laboratories's level of debt (16.7%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (72.5% vs 16.7% today).
  • Debt is well covered by operating cash flow (112%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 7.1x coverage).
X
Financial health checks
We assess Jyothy Laboratories's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Jyothy Laboratories has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Jyothy Laboratories's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
2.02%
Current annual income from Jyothy Laboratories dividends. Estimated to be 2.5% next year.
If you bought ₹2,000 of Jyothy Laboratories shares you are expected to receive ₹40 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Jyothy Laboratories's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.55%).
  • Jyothy Laboratories's dividend is below the markets top 25% of dividend payers in India (2.09%).
Upcoming dividend payment

Purchase Jyothy Laboratories before the 'Buy Limit' to receive their next dividend payment.

Dividends are usually paid every 3 or 6 months, you can time your share purchase to take advantage of upcoming dividend payments.
Dividend payment calendar
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NSEI:JYOTHYLAB Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 9 Analyst Estimates (S&P Global) See Below
Asia Household Products Industry Average Dividend Yield Market Cap Weighted Average of 5 Stocks 1.3%
India Market Average Dividend Yield Market Cap Weighted Average of 1398 Stocks 1.4%
India Minimum Threshold Dividend Yield 10th Percentile 0.3%
India Bottom 25% Dividend Yield 25th Percentile 0.6%
India Top 25% Dividend Yield 75th Percentile 2.1%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NSEI:JYOTHYLAB Future Dividends Estimate Data
Date (Data in ₹) Dividend per Share (annual) Avg. No. Analysts
2022-03-31 4.50 1.00
2021-03-31 3.80 6.00
2020-03-31 3.47 5.00
NSEI:JYOTHYLAB Past Annualized Dividends Data
Date (Data in ₹) Dividend per share (annual) Avg. Yield (%)
2019-05-07 3.000 1.949
2018-05-16 0.500 0.253
2017-05-18 3.000 1.611
2016-05-23 2.500 1.499
2016-03-10 2.000 1.338
2015-07-06 2.000 1.334
2015-05-25 2.000 1.413
2014-10-07 2.000 1.543
2014-01-28 1.000 1.003
2013-07-19 1.250 1.418
2013-05-22 1.250 1.340
2012-07-10 0.625 0.795
2012-05-23 0.625 1.115
2011-09-22 1.250 3.069
2010-08-10 1.000 1.717
2010-05-25 1.000 1.605
2009-06-05 0.500 1.424

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of Jyothy Laboratories's earnings are paid to the shareholders as a dividend.
  • Dividends paid are covered by earnings (1.9x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be covered by earnings (1.9x coverage).
X
Income/ dividend checks
We assess Jyothy Laboratories's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Jyothy Laboratories afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Jyothy Laboratories has a total score of 4/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Jyothy Laboratories's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Moothedath Ramachandran
COMPENSATION ₹40,296,403
AGE 72
TENURE AS CEO 36.3 years
CEO Bio

Mr. Moothedath Panjan Ramachandran is the Founder of Jyothy Laboratories Limited and has been its Chairman and Managing Director since 1983. Mr. Ramachandran began his career as an accountant in 1971 in Mumbai. He set up Jyothy Laboratories business in 1983. He has over 37 years of experience in sales, production and general management. He has been an Executive Director at Jyothy Laboratories Ltd since 1983. In 2003 and 2004, he was nominated by The Economics Times for Entrepreneur of the Year Award. He serves as a Director of Jyothy Consumer Products Marketing Limited. Mr. Ramachandran holds a Postgraduate degree in Financial Management from University of Mumbai.

CEO Compensation
  • Moothedath's compensation has been consistent with company performance over the past year.
  • Moothedath's remuneration is higher than average for companies of similar size in India.
Management Team Tenure

Average tenure and age of the Jyothy Laboratories management team in years:

3
Average Tenure
51
Average Age
  • The tenure for the Jyothy Laboratories management team is about average.
Management Team

Moothedath Ramachandran

TITLE
Founder
COMPENSATION
₹40M
AGE
72
TENURE
36.3 yrs

Kasaragod Kamath

TITLE
Joint MD
COMPENSATION
₹73M
AGE
55
TENURE
7.3 yrs

Raghunandan Rao

TITLE
President
AGE
53
TENURE
3 yrs

Rajnikant Sabnavis

TITLE
Chief Operating Officer
AGE
51
TENURE
3 yrs

Shreyas Trivedi

TITLE
Head of Legal
COMPENSATION
₹7M

Moothedath Jyothy

TITLE
Chief Marketing Officer & Whole-Time Director
COMPENSATION
₹22M
AGE
40

Venkitachalam Iyer

TITLE
Head of Corporate Sales
AGE
56

Neetu Kashiramka

TITLE
Vice President of Finance
AGE
44

S. Somasundaram

TITLE
Vice President of Supply Sourcing & Manufacturing
AGE
48

Sanjay Agarwal

TITLE
Chief Financial Officer
AGE
42
TENURE
1 yrs
Board of Directors Tenure

Average tenure and age of the Jyothy Laboratories board of directors in years:

15
Average Tenure
55.5
Average Age
  • The average tenure for the Jyothy Laboratories board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Moothedath Ramachandran

TITLE
Founder
COMPENSATION
₹40M
AGE
72
TENURE
36.3 yrs

Kasaragod Kamath

TITLE
Joint MD
COMPENSATION
₹73M
AGE
55
TENURE
22.3 yrs

Moothedath Jyothy

TITLE
Chief Marketing Officer & Whole-Time Director
COMPENSATION
₹22M
AGE
40
TENURE
13.6 yrs

Nilesh Mehta

TITLE
Independent Director
COMPENSATION
₹950K
AGE
56
TENURE
16.3 yrs

Ramakrishnan Lakshminarayanan

TITLE
Independent Director
COMPENSATION
₹930K
AGE
62
TENURE
7 yrs

Bhumika Batra

TITLE
Independent Director
AGE
37
TENURE
0.2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (₹) Value (₹)
14. Dec 18 Buy Moothedath Ramachandran Individual 13. Dec 18 13. Dec 18 3,366,975 ₹185.45 ₹624,405,340
04. Sep 18 Sell S. Somasundaram Individual 30. Aug 18 30. Aug 18 -14,000 ₹212.93 ₹-2,980,999
X
Management checks
We assess Jyothy Laboratories's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Jyothy Laboratories has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

What Kind Of Shareholders Own Jyothy Laboratories Limited (NSE:JYOTHYLAB)?

See our latest analysis for Jyothy Laboratories NSEI:JYOTHYLAB Ownership Summary, May 11th 2019 What Does The Institutional Ownership Tell Us About Jyothy Laboratories? … Insider Ownership Of Jyothy Laboratories The definition of company insiders can be subjective, and does vary between jurisdictions. … Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual.

Simply Wall St -

What To Know Before Buying Jyothy Laboratories Limited (NSE:JYOTHYLAB) For Its Dividend

Dividend paying stocks like Jyothy Laboratories Limited (NSE:JYOTHYLAB) tend to be popular with investors, and for good reason - some research shows that a significant amount of all stock market returns come from reinvested dividends. … Yet sometimes, investors buy a popular dividend stock because of its yield, and then lose money if the company's dividend doesn't live up to expectations. … Some simple analysis can offer a lot of insight when buying a company for its dividend, and we'll go through these below.

Simply Wall St -

Could The Jyothy Laboratories Limited (NSE:JYOTHYLAB) Ownership Structure Tell Us Something Useful?

If you want to know who really controls Jyothy Laboratories Limited (NSE:JYOTHYLAB), then you'll have to look at the makeup of its share registry. … Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. … View our latest analysis for Jyothy Laboratories

Simply Wall St -

Is Jyothy Laboratories Limited's (NSE:JYOTHYLAB) Balance Sheet A Threat To Its Future?

However, an important fact which most ignore is: how financially healthy is the business? … Understanding the company's financial health becomes. … Let's work through some financial health checks you may wish to consider if you're interested in this stock.

Simply Wall St -

If You Had Bought Jyothy Laboratories Stock Five Years Ago, You Could Pocket A 86% Gain Today

For example, the Jyothy Laboratories Limited (NSE:JYOTHYLAB) share price is 86% higher than it was five years ago, which is more than the market average. … One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. … During five years of share price growth, Jyothy Laboratories achieved compound earnings per share (EPS) growth of 54% per year.

Simply Wall St -

Is Jyothy Laboratories Limited (NSE:JYOTHYLAB) Overpaying Its CEO?

In 1983 Moothedath Ramachandran was appointed CEO of Jyothy Laboratories Limited (NSE:JYOTHYLAB). … First, this article will compare CEO compensation with compensation at similar sized companies. … How Does Moothedath Ramachandran's Compensation Compare With Similar Sized Companies?

Simply Wall St -

Is Jyothy Laboratories Limited’s (NSE:JYOTHYLAB) Return On Capital Employed Any Good?

To be precise, we'll consider its Return On Capital Employed (ROCE), as that will inform our view of the quality of the business. … Understanding Return On Capital Employed (ROCE). … ROCE measures the amount of pre-tax profits a company can generate from the capital employed in its business.

Simply Wall St -

Why You Should Care About Jyothy Laboratories Limited’s (NSE:JYOTHYLAB) Cash Levels

I’ve analysed below, the health and outlook of Jyothy Laboratories’s cash flow, which will help you understand the stock from a cash standpoint. … What is Jyothy Laboratories's cash yield. … I will be analysing Jyothy Laboratories’s FCF by looking at its FCF yield and its operating cash flow growth.

Simply Wall St -

How Many Insiders Sold Jyothy Laboratories Limited (NSE:JYOTHYLAB) Shares?

So we'll take a look at whether insiders have been buying or selling shares in Jyothy Laboratories Limited (NSE:JYOTHYLAB). … But logic dictates you should pay some attention to whether insiders are buying or selling shares. … The Last 12 Months Of Insider Transactions At Jyothy Laboratories

Simply Wall St -

Jyothy Laboratories Limited (NSE:JYOTHYLAB): Poised For Long-Term Success?

In March 2018, Jyothy Laboratories Limited (NSE:JYOTHYLAB) announced its latest earnings update, whicha

Simply Wall St -

Company Info

Description

Jyothy Laboratories Limited, together with its subsidiaries, manufactures and markets detergents, soaps, and mosquito repellents in India and internationally. It operates through Dishwashing, Fabric Care, Household Insecticides, Personal Care, Laundry Services, and Others segments. The Dishwashing segment offers dish wash scrubbers and scrubber steel, as well as dish wash bars, liquids, and powders under the Pril and Exo brands. The Fabric Care segment provides fabric whiteners, fabric enhancers, bar soaps, and detergent powders under the Henko, Mr. White, Ujala, More light, and New Super Chek brands. The Household Insecticides segment offers mosquito repellent coils, liquids, and cards, as well as insect repellents and air care products under the Maya, Exo Floor Shine, and Maxo brands. The Personal Care segment provides body soaps, face washes, toothpastes, deodorants, talcum powders, after shave products, and moisturizers under the Margo, Fa, and Neem Active Toothpaste brands. The Laundry Services segment provides dry cleaning and laundry services. The Others segment offers incense sticks and floor shine products. Jyothy Laboratories Limited was founded in 1983 and is based in Mumbai, India.

Details
Name: Jyothy Laboratories Limited
JYOTHYLAB
Exchange: NSEI
Founded: 1983
₹54,603,925,362
367,208,644
Website: http://www.jyothylaboratories.com
Address: Jyothy Laboratories Limited
Ujala House,
Ramkrishna Mandir Road,
Mumbai,
Maharashtra, 400059,
India
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
BSE 532926 Equity Shares Mumbai Stock Exchange IN INR 02. Jan 2008
NSEI JYOTHYLAB Equity Shares National Stock Exchange of India IN INR 02. Jan 2008
Number of employees
Current staff
Staff numbers
0
Jyothy Laboratories employees.
Industry
Household Products
Household
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/19 13:02
End of day share price update: 2019/05/17 00:00
Last estimates confirmation: 2019/05/09
Last earnings filing: 2019/05/07
Last earnings reported: 2019/03/31
Last annual earnings reported: 2019/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.